PBS listing – Ferro-Tabs

AFT Pharmaceuticals is pleased to announce that from 01 September 2011 it’s iron replacement product Ferro-Tabs will be PBS Listed.

“This will make iron replacement therapy more readily available for groups in need such as indigenous peoples or the elderly and will assist in the implementation of the recommendations made by the National Iron Deficiency Anaemia expert groups,” said Group CEO, Dr Hartley Atkinson.

July 23, 2026

Pitt St Research initiates coverage on AFT Pharmaceuticals

AFT Pharmaceuticals (NZX: AFT; ASX: AFP), today announces that Pitt St Research has initiated coverage on AFT Pharmaceuticals Ltd….

Read More

May 21, 2026

AFT delivers double digit revenue growth and record earnings

Operating profit or $24.4 million ahead of the guidance range….

Read More

May 18, 2026

AFT Pharmaceuticals names Stuart Houliston CFO

AFT Pharmaceuticals (NZX: AFT; ASX: AFP), New Zealand’s largest domestic pharmaceuticals company, today advises that Stuart Houliston will commence …

Read More